Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.82	83.01	98.43	156.15	59.77	168.2
Short-Term Investments	192.66	315.97	368.63	311.14	230.69	42.01
Cash & Short-Term Investments	265.48	398.98	467.07	467.29	290.47	210.21
Cash Growth	-59.93%	-14.58%	-0.05%	60.88%	38.18%	113.13%
Other Receivables	-	6.46	-	-	-	-
Receivables	-	6.46	-	-	-	-
Prepaid Expenses	10.43	9.23	13.12	7.18	6.1	2.07
Total Current Assets	275.91	414.67	480.19	474.47	296.56	212.28
Property, Plant & Equipment	1.75	2.35	3.53	5.3	0.08	0.13
Long-Term Investments	242.3	204.44	-	80.88	140.4	-
Other Long-Term Assets	0.37	0.37	0.46	0.46	0.15	2.3
Total Assets	520.33	621.82	484.18	561.12	437.19	214.71
Accounts Payable	2.46	1.68	2.49	2.66	3.17	9.68
Accrued Expenses	21.97	26.23	23.29	12	7.6	4.64
Short-Term Debt	-	-	-	0.18	-	-
Current Portion of Leases	1.39	1.3	1.44	1.42	-	-
Current Income Taxes Payable	-	-	-	4.28	-	-
Other Current Liabilities	2.23	1.44	0.91	1.96	0.97	-
Total Current Liabilities	28.06	30.65	28.14	22.5	11.75	14.32
Long-Term Leases	0.13	0.85	2.15	3.59	-	-
Other Long-Term Liabilities	-	-	-	-	0.07	0.07
Total Liabilities	28.18	31.5	30.29	26.09	11.81	14.39
Common Stock	0.01	0.01	0	0.01	0	0
Additional Paid-In Capital	978.33	958.7	654.69	585.32	584.71	292.35
Retained Earnings	-486.8	-368.24	-200.86	-47.7	-158.91	-93.34
Comprehensive Income & Other	0.61	-0.13	-0.13	-2.6	-0.84	-0
Total Common Equity	492.15	590.33	453.7	535.03	424.97	199.01
Minority Interest	-	-	0.19	-	0.4	1.3
Shareholders' Equity	492.15	590.33	453.9	535.03	425.37	200.31
Total Liabilities & Equity	520.33	621.82	484.18	561.12	437.19	214.71
Total Debt	1.52	2.15	3.59	5.19	-	-
Net Cash (Debt)	263.96	396.83	463.48	462.1	290.47	210.21
Net Cash Growth	-59.99%	-14.38%	0.30%	59.09%	38.18%	113.13%
Net Cash Per Share	4.49	7.38	11.15	9.91	6.74	10.57
Filing Date Shares Outstanding	59.07	58.51	43.07	39.33	44.61	43.52
Total Common Shares Outstanding	59.07	58.51	42.9	45.8	44.29	2.02
Working Capital	247.85	384.02	452.05	451.97	284.82	197.96
Book Value Per Share	8.33	10.09	10.58	11.68	9.59	98.36
Tangible Book Value	492.15	590.33	453.7	535.03	424.97	199.01
Tangible Book Value Per Share	8.33	10.09	10.58	11.68	9.59	98.36
Machinery	-	0.77	0.77	0.68	0.2	0.2
Leasehold Improvements	-	0.58	0.58	0.63	0.11	0.11

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q